260 related articles for article (PubMed ID: 26514101)
1. Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism.
Shaya SA; Saldanha LJ; Vaezzadeh N; Zhou J; Ni R; Gross PL
J Thromb Haemost; 2016 Jan; 14(1):143-52. PubMed ID: 26514101
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi.
Shaya SA; Gani DM; Weitz JI; Kim PY; Gross PL
Thromb Haemost; 2019 Jun; 119(6):992-999. PubMed ID: 31005064
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model.
Chessum JE; Shaya SA; Rajab D; Aftabjahani A; Zhou J; Weitz JI; Gross PL; Kim PY
J Thromb Haemost; 2024 Jan; 22(1):263-270. PubMed ID: 37751849
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ
Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291
[TBL] [Abstract][Full Text] [Related]
5. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.
Li M; Li J; Wang X; Hui X; Wang Q; Xie S; Yan P; Tian J; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010957. PubMed ID: 37057837
[TBL] [Abstract][Full Text] [Related]
6. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
8. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
Ageno W; Casella IB; Han CK; Raskob GE; Schellong S; Schulman S; Singer DE; Kimura K; Tang W; Desch M; Goldhaber SZ
Thromb Haemost; 2017 Jan; 117(2):415-421. PubMed ID: 27853808
[TBL] [Abstract][Full Text] [Related]
9. Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
Partsch H; Kechavarz B; Mostbeck A; Köhn H; Lipp C
J Vasc Surg; 1996 Nov; 24(5):774-82. PubMed ID: 8918323
[TBL] [Abstract][Full Text] [Related]
10. Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk.
Kattula S; Sang Y; de Ridder G; Silver AC; Bouck EG; Cooley BC; Wolberg AS
J Thromb Haemost; 2021 Dec; 19(12):2997-3007. PubMed ID: 34431201
[TBL] [Abstract][Full Text] [Related]
11. Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.
Halton JML; Albisetti M; Biss B; Bomgaars L; Brueckmann M; Gropper S; Harper R; Huang F; Luciani M; Maas H; Tartakovsky I; Mitchell LG
J Thromb Haemost; 2017 Nov; 15(11):2147-2157. PubMed ID: 28921890
[TBL] [Abstract][Full Text] [Related]
12. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.
Monreal M; Büller H; Lensing AW; Bonet M; Roncales J; Muchart J; Fraile M
Thromb Haemost; 2002 Dec; 88(6):938-42. PubMed ID: 12529742
[TBL] [Abstract][Full Text] [Related]
13. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.
Francis CW; Kessler CM; Goldhaber SZ; Kovacs MJ; Monreal M; Huisman MV; Bergqvist D; Turpie AG; Ortel TL; Spyropoulos AC; Pabinger I; Kakkar AK
J Thromb Haemost; 2015 Jun; 13(6):1028-35. PubMed ID: 25827941
[TBL] [Abstract][Full Text] [Related]
14. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
[TBL] [Abstract][Full Text] [Related]
15. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
Worley S; Short C; Pike J; Anderson D; Douglas JA; Thompson K
J Spinal Cord Med; 2008; 31(4):379-87. PubMed ID: 18959355
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
[TBL] [Abstract][Full Text] [Related]
17. Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
Jugrin AV; Hösel V; Ustyugova A; De Francesco M; Lamotte M; Sunderland T
J Med Econ; 2016; 19(1):1-10. PubMed ID: 26390231
[TBL] [Abstract][Full Text] [Related]
18. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.
Robertson L; Kesteven P; McCaslin JE
Cochrane Database Syst Rev; 2015 Jun; (6):CD010956. PubMed ID: 26123214
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
